Selective activation of the hypothalamic vasopressinelgic system in mice deficient for the corticotropin-releasing hormone receptor 1 is dependent onglucocorticoids
Mb. Muller et al., Selective activation of the hypothalamic vasopressinelgic system in mice deficient for the corticotropin-releasing hormone receptor 1 is dependent onglucocorticoids, ENDOCRINOL, 141(11), 2000, pp. 4262-4269
Deficiency of CRH receptor 1 (CRHR1) severely impairs the stress response o
f the hypothalamic-pituitary-adrenocortical (HPA) system and reduces anxiet
y-related behavior in mice. Intriguingly, in mice deficient for the CRHR1 (
Crhr1(-/-)), basal plasma levels of ACTH are normal, suggesting the presenc
e of compensatory mechanisms for pituitary ACTH secretion. We therefore stu
died the impact of the hypothalamic neuropeptides arginine vasopressin (AVP
) and oxytocin (OXT) on HPA system regulation in homozygous and heterozygou
s Crhr1 mutants under basal and different stress conditions. Basal plasma A
VP concentrations were significantly elevated in Crhr1(-/-) mice. AW messen
ger RNA expression was increased in the paraventricular nucleus of Crhr1(-/
-) mutants together with a marked increase in AW-like immunoreactivity in t
he median eminence. Administration of an AVP V-1-receptor antagonist signif
icantly decreased basal plasma ACTH levels in mutant mice. After continuous
treatment with corticosterone, plasma AVP levels in homozygous Crhr1(-/-)
mice were indistinguishable from those in wild-type littermates, thus provi
ding evidence that glucocorticoid deficiency is the major driving force beh
ind compensatory activation of the vasopressinergic system in Crhr1(-/-) mi
ce. Neither plasma OXT levels under several different conditions nor OXT me
ssenger RNA expression in the paraventricular nucleus were different betwee
n the genotypes. Taken together, our data reveal a selective compensatory a
ctivation of the hypothalamic vasopressinergic, but not the oxytocinergic s
ystem, to maintain basal ACTH secretion and HPA system activity in Crhr1(-/
-) mutants.